Evidence map›Paper›PMID 32886728›Full record

ArticlePloS one2020

Corneal dysfunction precedes the onset of hyperglycemia in a mouse model of diet-induced obesity.

Aubrey Hargrave, Justin A Courson, Vanna Pham, Paul Landry, Sri Magadi, Pooja Shankar, Sam Hanlon, Apoorva Das, Rolando E Rumbaut, C Wayne Smith and 1 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
2.0field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 23 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Observational
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. An Epithelial Abrasion Model for Studying Corneal Wound Healing.Journal of visualized experiments : JoVE · 2021
    Article
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 1 country.

Aubrey HargraveCollege of Optometry, University of Houston, Houston, Texas, United States of America.ORCID 0000-0002-5471-9331
Justin A CoursonCollege of Optometry, University of Houston, Houston, Texas, United States of America.
Vanna PhamCollege of Optometry, University of Houston, Houston, Texas, United States of America.
Paul LandryCollege of Optometry, University of Houston, Houston, Texas, United States of America.
Sri MagadiCollege of Optometry, University of Houston, Houston, Texas, United States of America.
Pooja ShankarCollege of Optometry, University of Houston, Houston, Texas, United States of America.
Sam HanlonCollege of Optometry, University of Houston, Houston, Texas, United States of America.
Apoorva DasCollege of Optometry, University of Houston, Houston, Texas, United States of America.
Rolando E RumbautChildren's Nutrition Research Center, Baylor College of Medicine, Houston, Texas, United States of America.
C Wayne SmithCenter for Translational Research on Inflammatory Diseases (CTRID), Michael E. DeBakey Veterans Affairs Medical Center, Houston, Texas, United States of America.
Alan R BurnsCollege of Optometry, University of Houston, Houston, Texas, United States of America.
University of Houston · USMichael E. DeBakey VA Medical Center · USChildren's Nutrition Research Center at Baylor College of Medicine · US

Funding

Research Programming ModuleP30EY007551 · NEI · UNIVERSITY OF HOUSTON · PI GEUNYOUNG YOON · 1988 to 2026
$16.4M
OCULAR SURFACE INJURY: INFLAMMATORY CASCADE AND HEALING OF CORNEAL WOUNDSR01EY018239 · NEI · BAYLOR COLLEGE OF MEDICINE · PI BURNS, ALAN R, RUMBAUT, ROLANDO E · 2008 to 2020
$3.7M
Platelets and microvascular thrombosis in inflammationI01BX002551 · VA · MICHAEL E DEBAKEY VA MEDICAL CENTER · PI RUMBAUT, ROLANDO E · 2016 to 2025
–
6 · The paper itself

Abstract

purposeThe purpose of this study was to use a mouse model of diet-induced obesity to determine if corneal dysfunction begins prior to the onset of sustained hyperglycemia and if the dysfunction is ameliorated by diet reversal.

methodsSix-week-old male C57BL/6 mice were fed a high fat diet (HFD) or a normal diet (ND) for 5-15 weeks. Diet reversal (DiR) mice were fed a HFD for 5 weeks, followed by a ND for 5 or 10 weeks. Corneal sensitivity was determined using aesthesiometry. Corneal cytokine expression was analyzed using a 32-plex Luminex assay. Excised corneas were prepared for immunofluorescence microscopy to evaluate diet-induced changes and wound healing. For wounding studies, mice were fed a HFD or a ND for 10 days prior to receiving a central 2mm corneal abrasion.

resultsAfter 10 days of HFD consumption, corneal sensitivity declined. By 10 weeks, expression of corneal inflammatory mediators increased and nerve density declined. While diet reversal restored nerve density and sensitivity, the corneas remained in a heightened inflammatory state. After 10 days on the HFD, corneal circadian rhythms (limbal neutrophil accumulation, epithelial cell division and Rev-erbα expression) were blunted. Similarly, leukocyte recruitment after wounding was dysregulated and accompanied by delays in wound closure and nerve recovery.

conclusionIn the mouse, obesogenic diet consumption results in corneal dysfunction that precedes the onset of sustained hyperglycemia. Diet reversal only partially ameliorated this dysfunction, suggesting a HFD diet may have a lasting negative impact on corneal health that is resistant to dietary therapeutic intervention.

Indexed as

AnimalsBody CompositionCorneaDiet, High-FatDisease Models, AnimalHomeostasisHyperglycemiaLeukocytesMaleMiceMice, Inbred C57BLObesityTime FactorsWound Healing

Identifiers

PMID32886728
PMCPMC7473521
OpenAlexW3083590242

What OpenQuestion holds

Textmetadata
LicenceCC0
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.